Springer Protocols: Abstract: Testicular Germ Cell Tumors in Mice: New Ways to Study a Genetically Complex Trait

Testicular Germ Cell Tumors in Mice: New Ways to Study a Genetically Complex Trait

By: Jason D. Heaney³, Joseph H. Nadeau³

Abstract

Full Text

Download PDF (1179K)

Testicular germ cell tumors (TGCTs) are the most common cancer affecting young men. Although TGCTs are common and the genetic component of susceptibility is unusually strong, discovery of TGCT susceptibility genes in humans has been challenging. The 129/Sv inbred mouse strain is an important experimental model for studying the genetic control of TGCT susceptibility. It is the only inbred mouse strain with an appreciable frequency of spontaneous TGCTs. TGCTs in 129/Sv males share various developmental and histological characteristics with human pediatric TGCTs. As in humans, susceptibility in 129/Sv is a genetically complex trait that is too complex for conventional genetic approaches. However, several genetic variants, when congenic or isogenic on the 129/Sv background, act as genetic modifiers of TGCT susceptibility. Alternative experimental approaches based on these modifier genes can be used to unravel the complex genetic control of TGCT susceptibility. We discuss the application of modifier genes in genetic interaction tests and sensitized polygenic trait analyses toward the understanding of the complex genetics and biology of TGCT susceptibility in mice.

Affiliation(s): (3) Department of Genetics, Case Western Reserve University, Cleveland, OH

Book Title: Germline Stem Cells

Series: Methods in Molecular Biology | Volume: 450 | Pub. Date: Apr-01-2008 | Page Range: 211-231 | DOI: 10.1007/978-1-60327-214-8_15

Subject: Cell Biology

Key Words: Consomic - interaction - Mouse - Polygene - QTL - sensitized - susceptibility - testicular tumor - modifier

References

Download References

1.	1. Bishop, T. D., and Wing, A. (1998) Candidate regions for testicular cancer susceptibility genes. APMIS Suppl. 106, 64–72.

2.	2. Bosl, G. J., and Motzer, R. J. (1997) Testicular germ-cell cancer. N. Engl. J. Med. 337, 242–253.

3.	3. Oosterhuis, J. W., and Looijenga, L. H. (2005) Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer. 5, 210–222.

4.	4. Oosterhuis, J. W., Looijenga, L. H., van, E. J., and de, J. B. (1997) Chromosomal constitution and developmental potential of human germ cell tumors and teratomas. Cancer Genet. Cytogenet. 95, 96–102.

5.	5. Forman, D., Oliver, R. T., Brett, A. R., et al. (1992) Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br. J. Cancer. 65, 255–262.

6.	6. Lindelof, B., and Eklund, G. (2001) Analysis of hereditary component of cancer by use of a familial index by site. Lancet. 358, 1696–1698.

7.	7. Heimdal, K., Olsson, H., Tretli, S., Fossa, S. D., Borresen, A. L., and Bishop, D. T. (1997) A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br. J. Cancer. 75, 1084–1087.

8.	8. Stevens, L., and Little, C. C. (1954) Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl. Acad. Sci. U. S. A. 40, 1080–1087.

9.	9. Rapley, E. A., Crockford, G. P., Teare, D., et al. (2000) Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat. Genet. 24, 197–200.

10.	10. Nathanson, K. L., Kanetsky, P. A., Hawes, R., et al. (2005) The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am. J. Hum. Genet. 77, 1034–1043.

11.	11. Crockford, G. P. , Linger, R., Hockley, S., et al. (2006) Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum. Mol. Genet. 15, 443–451.

12.	12. Kunwar, P. S., Siekhaus, D. E., and Lehmann, R. (2006) In vivo migration: a germ cell perspective. Annu. Rev. Cell Dev. Biol. 22, 237–265.

13.	13. Tam, P. P., and Snow, M. H. (1981) Proliferation and migration of primordial germ cells during compensatory growth in mouse embryos. J. Embryol. Exp. Morphol. 64, 133–147.

14.	14. McLaren, A. (1984) Meiosis and differentiation of mouse germ cells. Symp. Soc. Exp. Biol. 38, 7–23.

15.	15. Stevens, L. C. (1967) The biology of teratomas. Adv. Morphog. 6, 1–31.

16.	16. Stevens, L. C. (1967) Origin of testicular teratomas from primordial germ cells in mice. J. Natl. Cancer Inst. 38, 549–552.

17.	17. Stevens, L. C. (1962) Testicular teratomas in fetal mice. J. Natl. Cancer Inst. 28, 247–267.

18.	18. Stevens, L. C. (1966) Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J. Natl. Cancer Inst. 37, 859–867.

19.	19. Park, S. Y. , and Jameson, J. L. (2005) Minireview: transcriptional regulation of gonadal development and differentiation. Endocrinology. 146, 1035–1042.

20.	20. Chaillet, J. R., Vogt, T. F., Beier, D. R., and Leder, P. (1991) Parental-specific methylation of an imprinted transgene is established during gametogenesis and progressively changes during embryogenesis. Cell. 66, 77–83.

21.	21. De, F. M. (2000) Regulation of primordial germ cell development in the mouse. Int. J. Dev. Biol. 44, 575–580.

22.	22. Lee, J., Inoue, K., Ono, R., et al. (2002) Erasing genomic imprinting memory in mouse clone embryos produced from d 11.5 primordial germ cells. Development. 129, 1807–1817.

23.	23. Sato, S., Yoshimizu, T., Sato, E., and Matsui, Y. (2003) Erasure of methylation imprinting of Igf2r during mouse primordial germ-cell development. Mol. Reprod. Dev. 65, 41–50.

24.	24. Stevens, L. C. (1964) Experimental production of testicular teratomas in mice. Proc. Natl. Acad. Sci. U. S. A. 52, 654–661.

25.	25. Matin, A., Collin, G. B., Varnum, D. S., and Nadeau, J. H. (1998) Testicular teratocarcinogen-esis in mice—a review. APMIS. 106, 174–182.

26.	26. Rodriguez, E., Mathew, S., Reuter, V., Ilson, D. H., Bosl, G. J., and Chaganti, R. S. (1992) Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res. 52, 2285–2291.

27.	27. Vos, A., Oosterhuis, J. W., de Jong, B., Buist, J., and Schraffordt, K. H. (1990) Cytogenetics of carcinoma in situ of the testis. Cancer Genet. Cytogenet. 46, 75–81.

28.	28. Looijenga, L. H., Verkerk, A. J., Dekker, M. C., van Gurp, R. J., Gillis, A. J., and Oosterhuis, J. W. (1998) Genomic imprinting in testicular germ cell tumours. APMIS. 106, 187–195.

29.	29. Stevens, L. C., and Hummel, K. P. (1957) A description of spontaneous congenital testicular teratomas in strain 129 mice. J. Natl. Cancer Inst. 18, 719–747.

30.	30. Matin, A., Collin, G. B., Asada, Y., Varnum, D., and Nadeau, J. H. (1999) Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain. Nat. Genet. 23, 237–240.

31.	31. Stevens, L. C., and Mackensen, J. A. (1961) Genetic and environmental influences on terato-carcinogenesis in mice. J. Natl. Cancer Inst. 27, 443–453.

32.	32. Gidekel, S., Pizov, G., Bergman, Y. , and Pikarsky, E. (2003) Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 4, 361–370.

33.	33. Noguchi, T., and Stevens, L. C. (1982) Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J. Natl. Cancer Inst. 69, 907–913.

34.	34. Youngren, K. K., Coveney, D., Peng, X., et al. (2005) The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature. 435, 360–364.

35.	35. Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Bradley, A., and Donehower, L. A. (1993) Genetic background alters the spectrum of tumors that develop in p53deficient mice. FASEB J. 7, 938–943.

36.	36. Kimura, T., Suzuki, A., Fujita, Y., et al. (2003) Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development. 130, 1691–1700.

37.	37. Di, V. D., Cito, L., Boccia, A., et al. (2005) Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene. 24, 1882–1894.

38.	38. Lam, M. Y. , and Nadeau, J. H. (2003) Genetic control of susceptibility to spontaneous testicu-lar germ cell tumors in mice. APMIS. 111, 184–190.

39.	39. Lamoreux, M. L., Wakamatsu, K., and Ito, S. (2001) Interaction of major coat color gene functions in mice as studied by chemical analysis of eumelanin and pheomelanin. Pigment Cell Res. 14, 23–31.

40.	40. Parant, J. M., and Lozano, G. (2003) Disrupting TP53 in mouse models of human cancers. Hum. Mutat. 21, 321–326.

41.	41. Moore, K. J., Swing, D. A., Copeland, N. G., and Jenkins, N. A. (1990) Interaction of the murine dilute suppressor gene (dsu) with 14 coat color mutations. Genetics. 125, 421–430.

42.	42. Lam, M. Y., Youngren, K. K., and Nadeau, J. H. (2004) Enhancers and suppressors of testicu-lar cancer susceptibility in single- and double-mutant mice. Genetics. 166, 925–933.

43.	43. Bolivar, V. J., Cook, M. N., and Flaherty, L. (2001) Mapping of quantitative trait loci with knockout/congenic strains. Genome Res. 11, 1549–1552.

44.	44. Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., and Sharp, J. J. (1997) Genetic variation among 129 substrains and its importance for targeted mutagene-sis in mice. Nat. Genet. 16, 19–27.

45.	45. Armstrong, N. J., Brodnicki, T. C., and Speed, T. P. (2006) Mind the gap: analysis of marker-assisted breeding strategies for inbred mouse strains. Mamm. Genome. 17, 273–287.

46.	46. Youngren, K. K., Nadeau, J. H., and Matin, A. (2003) Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications. Hum. Mol. Genet. 12, 389–398.

47.	47. Reusens, B., and Remacle, C. (2006) Programming of the endocrine pancreas by the early nutritional environment. Int. J. Biochem. Cell Biol. 38, 913–922.

48.	48. Wu, G., Bazer, F. W., Cudd, T. A., Meininger, C. J., and Spencer, T. E. (2004) Maternal nutrition and fetal development. J. Nutr. 134, 2169–2172.

49.	49. Levin, B. E. (2006) Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1107–1121.

50.	50. Fleming, T. P., Kwong, W. Y., Porter, R., et al. (2004) The embryo and its future. Biol. Reprod. 71, 1046–1054.

51.	51. Suomalainen, A. (1997) Mitochondrial DNA and disease. Ann. Med. 29, 235–246.

52.	52. Luft, R. (1994) The development of mitochondrial medicine. Proc. Natl. Acad. Sci. U. S. A. 91, 8731–8738.

53.	53. Morgan, H. D., Sutherland, H. G., Martin, D. I., and Whitelaw, E. (1999) Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 23, 314–318.

54.	54. Wolff, G. L., Kodell, R. L., Moore, S. R., and Cooney, C. A. (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 12, 949–957.

55.	55. Matin, A., and Nadeau, J. H. (2001) Sensitized polygenic trait analysis. Trends Genet. 17, 727–731.

56.	56. Tanksley, S. D. (1993) Mapping polygenes. Annu. Rev. Genet. 27, 205–233.

57.	57. Collin, G. B., Asada, Y., Varnum, D. S., and Nadeau, J. H. (1996) DNA pooling as a quick method for finding candidate linkages in multigenic trait analysis: an example involving susceptibility to germ cell tumors. Mamm. Genome. 7, 68–70.

58.	58. Smigielski, E. M., Sirotkin, K., Ward, M., and Sherry, S. T. (2000) dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 28, 352–355.

59.	59. Peters, L. L., Robledo, R. F., Bult, C. J., Churchill, G. A., Paigen, B. J., and Svenson, K. L. (2007) The mouse as a model for human biology: a resource guide for complex trait analysis. Nat. Rev. Genet. 8, 58–69.

60.	60. Silver, L. M. (1995) Mouse genetics: concepts and applications, Oxford University Press, New York.

61.	61. Khripin, Y. (2006) High-throughput genotyping with energy transfer-labeled primers. Methods Mol. Biol. 335, 215–240.

62.	62. Stephens, M., Sloan, J. S., Robertson, P. D., Scheet, P., and Nickerson, D. A. (2006) Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat. Genet. 38, 375–381.

63.	63. Romkes, M., and Buch, S. C. (2005) Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening. Methods Mol. Biol. 291, 399–414.

64.	64. Jordan, B., Charest, A., Dowd, J. F., et al. (2002) Genome complexity reduction for SNP genotyping analysis. Proc. Natl. Acad. Sci. U. S. A. 99, 2942–2947.

65.	65. Lindblad-Toh, K., Winchester, E., Daly, M. J., et al. (2000) Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat. Genet. 24, 381–386.

66.	66. Zhao, Z. Z., Nyholt, D. R., Le, L., et al. (2006) KRAS variation and risk of endometriosis. Mol. Hum. Reprod. 12, 671–676.

67.	67. Manly, K. F., and Olson, J. M. (1999) Overview of QTL mapping software and introduction to map manager QT. Mamm. Genome. 10, 327–334.

68.	68. Lander, E. S., Green, P., Abrahamson, J., et al. (1987) MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics. 1, 174–181.

69.	69. Manly, K. F., Cudmore, R. H., Jr., and Meer, J. M. (2001) Map Manager QTX, cross-platform software for genetic mapping. Mamm. Genome. 12, 930–932.

70.	70. Broman, K. W., Wu, H., Sen, S., and Churchill, G. A. (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics. 19, 889–890.

71.	71. Lander, E., and Kruglyak, L. (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11, 241–247.

72.	72. Churchill, G. A., and Doerge, R. W. (1994) Empirical threshold values for quantitative trait mapping. Genetics. 138, 963–971.

73.	73. Muller, A. J., Teresky, A. K., and Levine, A. J. (2000) A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc. Natl. Acad. Sci. U. S. A. 97, 8421–8426.

74.	74. Singer, J. B., Hill, A. E., Burrage, L. C., et al. (2004) Genetic dissection of complex traits with chromosome substitution strains of mice. Science. 304, 445–448.

75.	75. Nadeau, J. H., Singer, J. B., Matin, A., and Lander, E. S. (2000) Analysing complex genetic traits with chromosome substitution strains. Nat. Genet. 24, 221–225.

76.	76. Hill, A. E., Lander, E. S., and Nadeau, J. H. (2006) Chromosome substitution strains: a new way to study genetically complex traits. Methods Mol. Med. 128, 153–172.

Comments (Loading...)